{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:09:50Z","timestamp":1780643390917,"version":"3.54.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bbalip.2021.159022","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T23:21:12Z","timestamp":1627600872000},"page":"159022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of high-density lipoproteins in cardioprotection and in reverse remodeling: Therapeutic implications"],"prefix":"10.1016","volume":"1866","author":[{"given":"Bart","family":"De Geest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudit","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbalip.2021.159022_bb0005","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/hrt.75.4.330","article-title":"Cardioprotection: definition, classification, and fundamental principles","volume":"75","author":"Kubler","year":"1996","journal-title":"Heart"},{"issue":"18","key":"10.1016\/j.bbalip.2021.159022_bb0010","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"Thygesen","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.bbalip.2021.159022_bb0015","first-page":"553","article-title":"How is cardiac troponin released from injured myocardium?","volume":"7","author":"Mair","year":"2018","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"issue":"10","key":"10.1016\/j.bbalip.2021.159022_bb0020","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and reverse cholesterol transport","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.bbalip.2021.159022_bb0025","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacl.2018.04.001","article-title":"Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins","volume":"12","author":"Gillard","year":"2018","journal-title":"J. Clin. Lipidol."},{"issue":"2","key":"10.1016\/j.bbalip.2021.159022_bb0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-2275(20)43114-1","article-title":"The plasma lecithin:cholesterol acyltransferase reaction","volume":"9","author":"Glomset","year":"1968","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.bbalip.2021.159022_bb0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-4157(87)90013-X","article-title":"Mechanisms and consequences of cellular cholesterol exchange and transfer","volume":"906","author":"Phillips","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.bbalip.2021.159022_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.14797\/mdcj-15-1-47","article-title":"Revisiting reverse cholesterol transport in the context of high-density lipoprotein free cholesterol bioavailability","volume":"15","author":"Rosales","year":"2019","journal-title":"Methodist Debakey Cardiovasc. J."},{"issue":"1","key":"10.1016\/j.bbalip.2021.159022_bb0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.aogh.2013.12.001","article-title":"Regression of atherosclerosis: insights from animal and clinical studies","volume":"80","author":"Feig","year":"2014","journal-title":"Ann. Glob. Health"},{"issue":"1","key":"10.1016\/j.bbalip.2021.159022_bb0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCRESAHA.114.300760","article-title":"High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies","volume":"114","author":"Feig","year":"2014","journal-title":"Circ. Res."},{"issue":"20","key":"10.1016\/j.bbalip.2021.159022_bb0055","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1161\/hc4501.098952","article-title":"Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content","volume":"104","author":"Rong","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.bbalip.2021.159022_bb0060","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00109-011-0722-x","article-title":"Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies","volume":"89","author":"Van Craeyveld","year":"2011","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbalip.2021.159022_bb0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4172\/2157-7412.1000106","article-title":"Gene therapy targeting LDL cholesterol but not HDL cholesterol induces regression of advanced atherosclerosis in a mouse model of familial hypercholesterolemia","volume":"2","author":"Li","year":"2011","journal-title":"J. Genet. Syndr. Gene Ther."},{"issue":"10","key":"10.1016\/j.bbalip.2021.159022_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013424","article-title":"Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis","volume":"5","author":"Kassim","year":"2010","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bbalip.2021.159022_bb0075","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jamacardio.2018.2112","article-title":"Effect of infusion of high-density lipoprotein mimetic containing recombinant apolipoprotein A-I Milano on coronary disease in patients with an acute coronary syndrome in the MILANO-PILOT Trial: a randomized clinical trial","volume":"3","author":"Nicholls","year":"2018","journal-title":"JAMA Cardiol."},{"issue":"13","key":"10.1016\/j.bbalip.2021.159022_bb0080","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"Jama"},{"issue":"22","key":"10.1016\/j.bbalip.2021.159022_bb0085","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.bbalip.2021.159022_bb0090","doi-asserted-by":"crossref","unstructured":"Michael Gibson, C.; Korjian, S.; Tricoci, P.; Daaboul, Y.; Yee, M.; Jain, P.; Alexander, J. H.; Steg, P. G.; Lincoff, A. M.; Kastelein, J. J.; Mehran, R.; D'Andrea, D. M.; Deckelbaum, L. I.; Merkely, B.; Zarebinski, M.; Ophuis, T. O.; Harrington, R. A., Safety and tolerability of CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I, after acute myocardial infarction: The AEGIS-I trial (ApoA-I event reducing in ischemic syndromes I). Circulation 2016, 134 (24), 1918\u20131930.","DOI":"10.1161\/CIRCULATIONAHA.116.025687"},{"key":"10.1016\/j.bbalip.2021.159022_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ahj.2020.10.052","volume":"231","author":"Gibson","year":"2021","journal-title":"Am. Heart J."},{"issue":"10","key":"10.1016\/j.bbalip.2021.159022_bb0100","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.108.182063","article-title":"Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque","volume":"103","author":"Shaw","year":"2008","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bbalip.2021.159022_bb0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bbalip.2021.159022_bb0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0008-6363(98)00033-9","article-title":"A fresh look at reperfusion injury","volume":"38","author":"Piper","year":"1998","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.bbalip.2021.159022_bb0115","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bbalip.2021.159022_bb0120","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/01.RES.0000054201.60308.1A","article-title":"High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release","volume":"92","author":"Calabresi","year":"2003","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.bbalip.2021.159022_bb0125","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1172\/JCI119114","article-title":"Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death","volume":"98","author":"Krown","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bbalip.2021.159022_bb0130","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1172\/JCI116834","article-title":"Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart","volume":"92","author":"Yokoyama","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bbalip.2021.159022_bb0135","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1124\/jpet.104.070789","article-title":"Apolipoprotein A-IMilano and 1-palmitoyl-2-oleoyl phosphatidylcholine complex (ETC-216) protects the in vivo rabbit heart from regional ischemia-reperfusion injury","volume":"311","author":"Marchesi","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"13","key":"10.1016\/j.bbalip.2021.159022_bb0140","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/CIRCULATIONAHA.105.607135","article-title":"High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia\/reperfusion injury in vivo via the S1P3 lysophospholipid receptor","volume":"114","author":"Theilmeier","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.bbalip.2021.159022_bb0145","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.lfs.2007.06.021","article-title":"The protective effect of ApolipoproteinA-I on myocardial ischemia-reperfusion injury in rats","volume":"81","author":"Gu","year":"2007","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.bbalip.2021.159022_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077211","article-title":"Apolipoprotein a-I is a potential mediator of remote ischemic preconditioning","volume":"8","author":"Hibert","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbalip.2021.159022_bb0155","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/cvr\/cvp024","article-title":"Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1\/2: role of sphingosine-1-phosphate","volume":"82","author":"Frias","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2021.159022_bb0160","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fcvm.2019.00150","article-title":"An update on the multifaceted roles of STAT3 in the heart","volume":"6","author":"Harhous","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.bbalip.2021.159022_bb0165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2013.02.003","article-title":"HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity","volume":"228","author":"Frias","year":"2013","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.bbalip.2021.159022_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218432","article-title":"HDL protects against myocardial ischemia reperfusion injury via miR-34b and miR-337 expression which requires STAT3","volume":"14","author":"Pedretti","year":"2019","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bbalip.2021.159022_bb0175","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/CIRCRESAHA.120.316848","article-title":"Apo AI nanoparticles delivered post myocardial infarction moderate inflammation","volume":"127","author":"Richart","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2021.159022_bb0180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fphar.2016.00002","article-title":"Protective effects of HDL against ischemia\/reperfusion injury","volume":"7","author":"Gomaraschi","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.bbalip.2021.159022_bb0185","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1161\/ATVBAHA.119.312880","article-title":"Reciprocal multifaceted interaction between HDL (high-density lipoprotein) and myocardial infarction","volume":"39","author":"Sposito","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"411","key":"10.1016\/j.bbalip.2021.159022_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam6084","article-title":"High-density lipoprotein delivered after myocardial infarction increases cardiac glucose uptake and function in mice","volume":"9","author":"Heywood","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.bbalip.2021.159022_bb0195","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.jacc.2005.12.072","article-title":"Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction","volume":"47","author":"McNamara","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159022_bb0200","doi-asserted-by":"crossref","unstructured":"Ibanez, B.; James, S.; Agewall, S.; Antunes, M. J.; Bucciarelli-Ducci, C.; Bueno, H.; Caforio, A. L. P.; Crea, F.; Goudevenos, J. A.; Halvorsen, S.; Hindricks, G.; Kastrati, A.; Lenzen, M. J.; Prescott, E.; Roffi, M.; Valgimigli, M.; Varenhorst, C.; Vranckx, P.; Widimsky, P.; Group, E. S. C. S. D., 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 2018, 39 (2), 119\u2013177.","DOI":"10.5603\/KP.2018.0041"},{"issue":"3","key":"10.1016\/j.bbalip.2021.159022_bb0205","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.bbalip.2021.159022_bb0210","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.CIR.81.4.1161","article-title":"Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications","volume":"81","author":"Pfeffer","year":"1990","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.bbalip.2021.159022_bb0215","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2011.07.022","article-title":"Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry","volume":"58","author":"Gaasch","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159022_bb0220","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.bbalip.2021.159022_bb0225","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1067\/mhj.2001.113218","article-title":"Prognostic implications of left ventricular hypertrophy","volume":"141","author":"Vakili","year":"2001","journal-title":"Am. Heart J."},{"issue":"12","key":"10.1016\/j.bbalip.2021.159022_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8120620","article-title":"High-density lipoprotein-targeted therapies for heart failure","volume":"8","author":"Mishra","year":"2020","journal-title":"Biomedicines"},{"issue":"13","key":"10.1016\/j.bbalip.2021.159022_bb0235","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2174\/138161210791050997","article-title":"Gene therapy to improve high-density lipoprotein metabolism and function","volume":"16","author":"Van Craeyveld","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"11","key":"10.1016\/j.bbalip.2021.159022_bb0240","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/gt.2013.30","article-title":"Beneficial effects of selective HDL-raising gene transfer on survival, cardiac remodelling and cardiac function after myocardial infarction in mice","volume":"20","author":"Gordts","year":"2013","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.bbalip.2021.159022_bb0245","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0735-1097(84)80203-X","article-title":"Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement","volume":"4","author":"Erlebacher","year":"1984","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.bbalip.2021.159022_bb0250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2008.05.056","article-title":"Reconstituted high-density lipoprotein attenuates postinfarction left ventricular remodeling in rats","volume":"203","author":"Kiya","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159022_bb0255","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/978-3-319-09665-0_17","article-title":"Therapeutic potential of HDL in cardioprotection and tissue repair","volume":"224","author":"Van Linthout","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbalip.2021.159022_bb0260","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cardiores.2004.10.014","article-title":"Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology","volume":"65","author":"Gao","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"16","key":"10.1016\/j.bbalip.2021.159022_bb0265","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jacc.2007.12.040","article-title":"Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia\/reperfusion in rats","volume":"51","author":"Imaizumi","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.bbalip.2021.159022_bb0270","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jacc.2010.11.072","article-title":"Reconstituted high-density lipoprotein shortens cardiac repolarization","volume":"58","author":"Den Ruijter","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.bbalip.2021.159022_bb0275","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jacc.2010.12.048","article-title":"High-density lipoprotein shortens the ventricular action potential. A novel explanation for how statins prevent sudden arrhythmic death?","volume":"58","author":"Kirchhof","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.bbalip.2021.159022_bb0280","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.HYP.0000254415.31362.a7","article-title":"Role of oxidative stress in cardiac hypertrophy and remodeling","volume":"49","author":"Takimoto","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bbalip.2021.159022_bb0285","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI108079","article-title":"Wall stress and patterns of hypertrophy in the human left ventricle","volume":"56","author":"Grossman","year":"1975","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159022_bb0290","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.physiol.68.040104.124629","article-title":"Endothelial-cardiomyocyte interactions in cardiac development and repair","volume":"68","author":"Hsieh","year":"2006","journal-title":"Annu. Rev. Physiol."},{"issue":"5","key":"10.1016\/j.bbalip.2021.159022_bb0295","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1172\/JCI40096","article-title":"Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents","volume":"120","author":"Shimizu","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.bbalip.2021.159022_bb0300","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1172\/JCI32024","article-title":"Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice","volume":"117","author":"Tirziu","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bbalip.2021.159022_bb0305","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.HYP.0000215207.54689.31","article-title":"Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload","volume":"47","author":"Izumiya","year":"2006","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.bbalip.2021.159022_bb0310","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/jcmm.12567","article-title":"High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K\/Akt pathway","volume":"19","author":"Lin","year":"2015","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.bbalip.2021.159022_bb0315","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/HYPERTENSIONAHA.108.118919","article-title":"Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor","volume":"53","author":"Van Linthout","year":"2009","journal-title":"Hypertension"},{"issue":"37","key":"10.1016\/j.bbalip.2021.159022_bb0320","doi-asserted-by":"crossref","first-page":"34480","DOI":"10.1074\/jbc.M103782200","article-title":"Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids","volume":"276","author":"Nofer","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbalip.2021.159022_bb0325","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.RES.0000199272.59432.5b","article-title":"High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I","volume":"98","author":"Seetharam","year":"2006","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.bbalip.2021.159022_bb0330","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/bph.12174","article-title":"HDL and endothelial protection","volume":"169","author":"Tran-Dinh","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbalip.2021.159022_bb0335","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.RES.0000088351.58510.21","article-title":"Nitric oxide and cardiac function: ten years after, and continuing","volume":"93","author":"Massion","year":"2003","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.bbalip.2021.159022_bb0340","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu062","article-title":"Crosstalk between fibroblasts and inflammatory cells","volume":"102","author":"Van Linthout","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2021.159022_bb0345","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12950-016-0131-6","article-title":"Apolipoprotein A-I gene transfer exerts immunomodulatory effects and reduces vascular inflammation and fibrosis in ob\/ob mice","volume":"13","author":"Spillmann","year":"2016","journal-title":"J. Inflamm. (Lond.)"},{"key":"10.1016\/j.bbalip.2021.159022_bb0350","doi-asserted-by":"crossref","unstructured":"Mishra, M.; Muthuramu, I.; Aboumsallem, J. P.; Kempen, H.; De Geest, B., Reconstituted HDL (Milano) Treatment efficaciously reverses heart failure with preserved ejection fraction in mice. Int. J. Mol. Sci. 2018, 19 (11).","DOI":"10.3390\/ijms19113399"},{"issue":"8","key":"10.1016\/j.bbalip.2021.159022_bb0355","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1161\/ATVBAHA.115.305887","article-title":"High-density lipoproteins reduce endothelial-to-Mesenchymal transition","volume":"35","author":"Spillmann","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.bbalip.2021.159022_bb0360","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00109-015-1281-3","article-title":"Selective homocysteine-lowering gene transfer attenuates pressure overload-induced cardiomyopathy via reduced oxidative stress","volume":"93","author":"Muthuramu","year":"2015","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"9","key":"10.1016\/j.bbalip.2021.159022_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18092012","article-title":"Selective HDL-raising human Apo A-I gene therapy counteracts cardiac hypertrophy, reduces myocardial fibrosis, and improves cardiac function in mice with chronic pressure overload","volume":"18","author":"Amin","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bbalip.2021.159022_bb0370","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/ATVBAHA.118.310946","article-title":"Hepatocyte-specific SR-BI gene transfer corrects cardiac dysfunction in Scarb1-deficient mice and improves pressure overload-induced cardiomyopathy","volume":"38","author":"Muthuramu","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.bbalip.2021.159022_bb0375","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1161\/ATVBAHA.107.145474","article-title":"Increased oxidative stress in scavenger receptor BI knockout mice with dysfunctional HDL","volume":"27","author":"Van Eck","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.bbalip.2021.159022_bb0380","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.tem.2017.02.001","article-title":"SR-BI: a multifunctional receptor in cholesterol homeostasis and atherosclerosis","volume":"28","author":"Linton","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"issue":"21","key":"10.1016\/j.bbalip.2021.159022_bb0385","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1111\/bph.14463","article-title":"Successful treatment of established heart failure in mice with recombinant HDL (Milano)","volume":"175","author":"Aboumsallem","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbalip.2021.159022_bb0390","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.bbalip.2021.159022_bb0395","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.bbalip.2021.159022_bb0400","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.107.710830","article-title":"Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy","volume":"117","author":"Van Linthout","year":"2008","journal-title":"Circulation"},{"issue":"6779","key":"10.1016\/j.bbalip.2021.159022_bb0405","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbalip.2021.159022_bb0410","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00441-016-2445-3","article-title":"Reactive oxygen species and fibrosis: further evidence of a significant liaison","volume":"365","author":"Richter","year":"2016","journal-title":"Cell Tissue Res."},{"issue":"8","key":"10.1016\/j.bbalip.2021.159022_bb0415","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.111.255216","article-title":"Redox signaling in cardiac physiology and pathology","volume":"111","author":"Burgoyne","year":"2012","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.bbalip.2021.159022_bb0420","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0022-2275(20)33461-1","article-title":"Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1","volume":"41","author":"Navab","year":"2000","journal-title":"J. Lipid Res."},{"issue":"9","key":"10.1016\/j.bbalip.2021.159022_bb0425","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0022-2275(20)33462-3","article-title":"Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3","volume":"41","author":"Navab","year":"2000","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.bbalip.2021.159022_bb0430","first-page":"E68","volume":"20","author":"De Geest","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.bbalip.2021.159022_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061273","article-title":"Effective treatment of diabetic cardiomyopathy and heart failure with reconstituted HDL (Milano) in mice","volume":"20","author":"Aboumsallem","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbalip.2021.159022_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2009.07.031","article-title":"Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome","volume":"314","author":"Maury","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.bbalip.2021.159022_bb0445","first-page":"251","article-title":"Inflammation - cause or consequence of heart failure or both? Curr Heart Fail Rep","volume":"14","author":"Van Linthout","year":"2017"},{"issue":"11","key":"10.1016\/j.bbalip.2021.159022_bb0450","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11886-018-1067-7","article-title":"Tumor necrosis factor-alpha in heart failure: an updated review","volume":"20","author":"Schumacher","year":"2018","journal-title":"Curr. Cardiol. Rep."},{"issue":"7","key":"10.1016\/j.bbalip.2021.159022_bb0455","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: the cytokine hypothesis revisited","volume":"116","author":"Mann","year":"2015","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.bbalip.2021.159022_bb0460","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Hospitals, characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.bbalip.2021.159022_bb0465","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCHEARTFAILURE.111.966366","article-title":"Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction","volume":"5","author":"Dunlay","year":"2012","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.bbalip.2021.159022_bb0470","doi-asserted-by":"crossref","unstructured":"Ponikowski, P.; Voors, A. A.; Anker, S. D.; Bueno, H.; Cleland, J. G. F.; Coats, A. J. S.; Falk, V.; Gonzalez-Juanatey, J. R.; Harjola, V. P.; Jankowska, E. A.; Jessup, M.; Linde, C.; Nihoyannopoulos, P.; Parissis, J. T.; Pieske, B.; Riley, J. P.; Rosano, G. M. C.; Ruilope, L. M.; Ruschitzka, F.; Rutten, F. H.; van der Meer, P.; Group, E. S. C. S. D., 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2016, 37 (27), 2129\u20132200.","DOI":"10.1093\/eurheartj\/ehw128"},{"issue":"18","key":"10.1016\/j.bbalip.2021.159022_bb0475","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.110.954388","article-title":"Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum","volume":"123","author":"Borlaug","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bbalip.2021.159022_bb0480","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.bbalip.2021.159022_bb0485","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCHEARTFAILURE.112.972265","article-title":"HFpEF: cardiovascular abnormalities not just comorbidities","volume":"5","author":"Little","year":"2012","journal-title":"Circ. Heart Fail."},{"issue":"3","key":"10.1016\/j.bbalip.2021.159022_bb0490","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159022_bb0495","doi-asserted-by":"crossref","unstructured":"Solomon, S. D.; McMurray, J. J. V.; Committee, P.-H. S.; Investigators, Angiotensin-Neprilysin inhibition in heart failure with preserved ejection fraction. Reply. N. Engl. J. Med. 2020, 382 (12), 1182\u20131183.","DOI":"10.1056\/NEJMc2000284"},{"issue":"4","key":"10.1016\/j.bbalip.2021.159022_bb0500","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cpcardiol.2015.12.002","article-title":"Heart failure with preserved ejection fraction","volume":"41","author":"Reddy","year":"2016","journal-title":"Curr. Probl. Cardiol."},{"issue":"19","key":"10.1016\/j.bbalip.2021.159022_bb0505","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1056\/NEJMcp1511175","article-title":"Heart failure with preserved ejection fraction","volume":"375","author":"Redfield","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbalip.2021.159022_bb0510","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/s41598-020-65255-y","article-title":"Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension","volume":"10","author":"Mishra","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198121001505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198121001505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:11:03Z","timestamp":1761387063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198121001505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":102,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1388198121001505"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2021.159022","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of high-density lipoproteins in cardioprotection and in reverse remodeling: Therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2021.159022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"159022"}}